Physician profile
Eduardo Salcedo
NPI 1114955812
$838.96
in general payments reported to CMS, 2019-2025
10 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $46.53 · 2021: $114 · 2022: $81.77 · 2023: $48.34 · 2024: $155 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $299.67 | 2024-2025 | Zoryve |
| Abbvie INC. | $126.72 | 2019-2021 | |
| Smith+Nephew, INC. | $122.23 | 2019-2023 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Incyte Corporation | $99.99 | 2024 | |
| Veran Medical Technologies, INC. | $57.94 | 2019 | |
| Amgen INC. | $40.95 | 2022 | |
| Lifenet Health | $31.06 | 2023 | |
| Nestle Healthcare Nutrition INC. | $22.15 | 2022 | |
| Tactile Systems Technology INC | $20.65 | 2024 | Entre Plus, Flexitouch Plus |
| Aimmune Therapeutics, INC. | $17.60 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Salcedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.